New York A 4079: Establishes a long COVID-19 review board for the purpose of reviewing the research and data in the state on long COVID

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A04079 Summary:

BILL NOA04079 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORCunningham

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §2180, add §2184, Pub Health L

&nbsp

Establishes a long COVID-19 review board for the purpose of reviewing the research and data in the state on long COVID and developing and disseminating findings, recommendations, and best practices to contribute to the prevention of long COVID.

Go to top A04079 Actions:

BILL NOA04079 

&nbsp

01/31/2025referred to health

01/07/2026referred to health

Go to topA04079 Committee&nbspVotes:

Go to topA04079 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA04079 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 4079

 2025-2026 Regular Sessions

 IN ASSEMBLY

 January 31, 2025
 ___________

 Introduced by M. of A. CUNNINGHAM -- read once and referred to the
 Committee on Health

 AN ACT to amend the public health law, in relation to establishing a
 long COVID-19 review board

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Legislative intent. The legislature finds, determines and
 2 declares that COVID-19 has had a devastating impact on the state of New
 3 York. Since the first recorded death of a New York resident from the
 4 virus on March fourteenth, two thousand twenty, tens of thousands of New
 5 Yorkers have lost their lives to COVID-19. The sudden emergence and
 6 rapid spread of COVID-19 around the world has led to an evolving under-
 7 standing of the transmissibility, virulence, and symptoms of the virus
 8 by scientists and public health experts that continues to this day.
 9 There is growing awareness and concern about post-COVID conditions,
 10 sometimes referred to as "long COVID," in which a small but significant
 11 percentage of patients experience persistent symptoms weeks or months
 12 after recovering from their initial infection. It is vital that the
 13 state of New York commit to monitoring and tracking the long-term health
 14 impacts of COVID-19, even as effective vaccines are widely available.
 15 Studying New Yorkers who survived COVID-19 infection holds the promise
 16 of providing public health experts with information that may lead to a
 17 better understanding of trends in long-term illness and recovery, and
 18 the needs of survivors, particularly those suffering from post-COVID
 19 conditions.
 20 § 2. Section 2180 of the public health law is amended by adding a new
 21 subdivision 14 to read as follows:
 22 14. "Long COVID" means symptoms that persist after the acute COVID-19
 23 infection has resolved.
 24 § 3. The public health law is amended by adding a new section 2184 to
 25 read as follows:

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD02311-01-5

 A. 4079 2

 1 § 2184. Long COVID-19 study. 1. There is hereby established in the
 2 department the long COVID-19 review board for the purpose of reviewing
 3 the research and data in the state on long COVID and developing and
 4 disseminating findings, recommendations, and best practices to contrib-
 5 ute to the prevention of long COVID.
 6 2. (a) The board shall be composed of at least fifteen members, all of
 7 whom shall be appointed by the commissioner. The board shall be
 8 comprised of multidisciplinary experts in the field of virology, immu-
 9 nology, COVID-19 and public health, and shall include health care
 10 professionals or other experts who serve and are representative of the
 11 diversity of New Yorkers in medically underserved areas of the state or
 12 areas of the state with disproportionately high occurrences of COVID-19.
 13 (b) Board members shall serve for terms of three years. The commis-
 14 sioner may choose to reappoint board members to additional three-year
 15 terms.
 16 (c) A majority of the appointed membership of the board shall consti-
 17 tute a quorum.
 18 (d) If any member of the state board fails to attend three consecutive
 19 regular meetings, unless such absence is for good cause, that membership
 20 may be deemed vacant for purposes of the appointment of a successor.
 21 (e) Meetings of the state board shall be held at least twice a year
 22 but ma